Stephenson Harwood advised Dr. Falk on the deal. Dr. Falk Pharma GmbH completed the acquisition of Kynos Therapeutics Ltd, a clinical stage biopharmaceutical company focusing on...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood advised BenevolentAI on strategic collaboration with Merck. BenevolentAI has entered into a strategic collaboration with Merck. This collaboration will leverage BenevolentAI’s comprehensive AI platform...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood advised Bicycle Therapeutics on radiotherapy deal with Bayer. Bayer and Bicycle Therapeutics plc have announced a strategic collaboration agreement to develop, manufacture, and commercialize...
You must be a Standard 1 Year member to access this content.
Stephenson Harwood LLP advised AIM-listed Focusrite plc. Focusrite plc acquired Sonnox Limited. Focusrite is a global music and audio products group supplying hardware and software used...
You must be a Standard 1 Year member to access this content.
